Advertisement Applied Biosystems, BioTrove strike deal for genotyping applications - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Applied Biosystems, BioTrove strike deal for genotyping applications

Applied Biosystems has signed a licensing and collaboration agreement with BioTrove to commercialize an analysis platform for high-throughput genotyping applications.

Under terms of the agreement, Applied Biosystems retains the rights to commercialize all genotyping applications, including assays other than ones based on TaqMan technology, for BioTrove’s platform. Applied Biosystems plans to commercialize and service all components of this analysis platform during the second half of 2008. Applied Biosystems is also retaining an option to collaborate with BioTrove for developing and commercializing the OpenArray platform for high-throughput gene expression applications.

Applied Biosystems will develop and market custom-built arrays of TaqMan SNP genotyping assays pre-loaded on BioTrove’s OpenArray platform. According to Applied Biosystems, this platform will integrate the ease-of-use, accuracy, and reproducibility of its TaqMan SNP genotyping assays with BioTrove’s flexible high-density assay format, enabling researchers to rapidly perform high-throughput genotyping studies at a lower total cost compared to alternative commercially available methods.

In a separate agreement, Applied Biosystems has granted a worldwide license under patent rights related to real-time thermal cyclers, microfluidics and data analysis to BioTrove. Under the agreement, BioTrove will have the right to manufacture and sell real-time thermal cyclers and array sample loaders in the life-sciences research field, as well as to develop further real-time PCR applications for its OpenArray platform.

Al Luderer, president and CEO of BioTrove, said: “The strength of the product design resulting from this collaboration provides researchers in public and private industries with the speed, flexibility and cost-effectiveness of the BioTrove OpenArray platform and the specificity and reproducibility of Applied Biosystems’s comprehensive line of TaqMan assay products – all in a single solution. By streamlining researchers’ genotyping workflows, we are accelerating the discovery and utilization of science impacting public health—from healthier foods to better health care.”